Safety and sedation-associated adverse event reporting among patients undergoing endoscopic cholangiopancreatography: a comparative systematic review and meta-analysis.

Thomas R McCartyKelly E HathornDavid W CreightonMohd Amer AlSammanChristopher C Thompson

Published in: Surgical endoscopy (2021)

This study suggests MAC may be a safe alternative to GETA for ERCP; however, MAC may not be appropriate in all patients given an increased risk of hypoxemia.

Keyphrases

patients undergoing
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
adverse drug
patient reported outcomes